Analysen von Ryan Martins
| 27.04.11 | Biogen equal-weight | Barclays Capital | |
| 18.04.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 15.03.11 | Synta Pharmaceuticals equal-weight | Barclays Capital | |
| 11.03.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 01.03.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 03.02.11 | Biogen equal-weight | Barclays Capital | |
| 27.01.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 24.01.11 | Biogen equal-weight | Barclays Capital | |
|
Werbung
|
|||
| 19.01.11 | Amylin Pharmaceuticals equal-weight | Barclays Capital | |
| 13.01.11 | Sanofi equal-weight | Barclays Capital | |
| 20.12.10 | Biogen equal-weight | Barclays Capital | |
| 20.12.10 | Amylin Pharmaceuticals equal-weight | Barclays Capital | |
| 13.12.10 | Biogen equal-weight | Barclays Capital | |
| 08.11.10 | Gilead Sciences equal-weight | Barclays Capital | |
| 28.10.10 | Biogen equal-weight | Barclays Capital | |
| 26.10.10 | Sanofi equal-weight | Barclays Capital | |
| 22.10.10 | Biogen equal-weight | Barclays Capital | |
| 30.09.10 | Biogen equal-weight | Barclays Capital | |
| 15.09.10 | Gilead Sciences equal-weight | Barclays Capital | |